Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL
23 Sep 2016
Vaccination to improve the persistence of CD19 CAR T cells in relapsed ALL
DNA methylation as a mediator of in utero exposures on the risk of childhood ALL
The timeline of adjuvant and neoadjuvant therapy for melanoma
Effects of ultraviolet light on underlying genes behind at-risk phenotypes
Metabolic regulation of melanoma cells
Developments in checkpoint immunotherapy
Targetted medicine to reduce melanoma mutational burden
VISMO trial to treat basal cell carcinoma
Checkpoint inhibitor therapy for treating melanoma
Metabolomics: Reversing drug resistance
Tumour heterogeneity and the impact on patient care
Developing new models in SCLC